Foreign hackers attempted a novel AI-powered cyberattack targeting two-factor authentication using a zero-day exploit. Google's Threat Intelligence Group detected and thwarted this sophisticated plot, ...

First AI zero-day: Google identified and blocked a zero-day exploit created with AI to bypass two-factor authentication on a widely used admin tool. Threat landscape shift: Experts say this confirms ...

Researchers at Google Threat Intelligence Group (GTIG) say that a zero-day exploit targeting a popular open-source web administration tool was likely generated using AI. The exploit could be leveraged ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

AI drug discovery specialist Generate Biomedicines has raised $400 million in the year’s largest initial public offering to date for a biotechnology firm. The company, which was launched in 2018 by ...

To use the extension, you need an API key from OpenAI or another OpenAI-compatible provider. How to Set or Change API Key When you first generate a docstring, a pop-up window will appear requesting ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Generate is indicative of a more mature startup that may have a better chance of succeeding in today’s markets. Industry IPOs peaked in 2021, resulting in a flood of companies whose early science didn ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...